Forex Tailwinds, New Product Launches Drive Dr Reddy’s PAT Up By 77% At Rs 1,247 Crore In Q3
Driven by foreign exchange positive aspects and new product launches, Dr Reddy's Laboratories Ltd’s consolidated revenue after tax (PAT) for ...
Driven by foreign exchange positive aspects and new product launches, Dr Reddy's Laboratories Ltd’s consolidated revenue after tax (PAT) for ...
Biggest help for Nifty50 at 15,671: Prashanth Tapse Prashanth Tapse, Vice President (Research) at Mehta Equities, is of the view ...
Dr. Reddy's Laboratories shares at the moment are in focus after the pharma main knowledgeable that it has entered an ...